Malin Corporation | MLC - Ordinary Share Capital


Malin Corporation reported EUR200K in Ordinary Share Capital for its fiscal semester ending in December of 2024.





Ordinary Share Capital Change Date
Akebia Therapeutics USD 265.42M 199K Dec/2025
Alaunos Therapeutics USD 2.38M 172K Mar/2026
ALKERMES USD 167.54M 1.08M Jun/2026
Dianthus Therapeutics USD 54.58M 11.36M Mar/2026
Eurofins Scientific SE EUR 172.35M 5.55M Jun/2026
Ionis Pharmaceuticals USD 165.64M 265K Jun/2026
IQVIA Holdings USD 164.6M 2.3M Jun/2026
Lonza CHF 68.64M 0 Dec/2025
Malin Corporation EUR 200K 0 Dec/2024
Moderna USD 391M 2M Sep/2025
Organon & Co USD 262.65M 2.33M Mar/2026
Ovoca Bio EUR 29.49M 0 Dec/2025
Revvity USD 111.63M 174K Jun/2026
Tectonic Therapeutic USD 18.83M 92.19K Mar/2026
Viatris USD 1.16B 5.27M Mar/2026
Xeris Pharmaceuticals USD 172.56M 6.34M Mar/2026